Amy Dyken, controller at Martgold Pharmaceutical industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Marigold s financialstatements. Belowis selected financial information for the fiscal year ended June 30,2020. \begin{tabular}{l} Marigold Pharmaceutical Industries \\ Selected Balance Sheet Information \\ June 30,2020 \\ \hline Long-term debt \end{tabular} Notes payable, 10% 8x convertible bonds payable 10xibonds payable. Total longterm debt Shareholders' equity Preferred stock, 7% cumulative, $50 par value. 101,000 shares authorized, 25,250 shares issued and outstanding Common stock, 51 par, 10,100,000 shares authorized. 1,010,000 shares issued and outstanding Additional paid in capital Retained earnings Total thareholders' equity The following transactions have akso occurred at Marigold 1. Options were granted on luty 1.2019, to purehase 180,000 shares at $16 per share. Although no options were exercised during fical year 2020 , the average price per comman share during fiseal year 2020 was $20 per share. 2. Each bond was issued at tace value the 8 convertible bonds will convert into common stock at 50 shares per 51.000 bond. The bonds are exerckable atter 5 years and were issued in niseal year 2019 3. The preferredstock was iswed in 2019 4. There are no preferred dividends in arreare; however, preferred dividends were not deciared in fical year 2020. 5. The 1.010.000 rraces of common stock were outt anding for the entire 2020 fiscal year. 6. Net income for tiscal year 2020 was 51,480.000, and the arerage income tax rate is 2008 . For the fical year ended june 30,2020 , cakculate the following for Marizold Pharmiceutical industries. (Round answers to 2 decimal places, e.s. 32,45 .) (a) Basic eamines per thare For the fiscal year ended June 30,2020 , calculate the following for Marigold Pharmaceutical Industries. (Round answers to 2 decimal places, e.8. $2.45.) (a) Basic earnings per share. Basic earnings per share (b) Diluted earnings per share. Diluted earnings per share Amy Dyken, controller at Martgold Pharmaceutical industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Marigold s financialstatements. Belowis selected financial information for the fiscal year ended June 30,2020. \begin{tabular}{l} Marigold Pharmaceutical Industries \\ Selected Balance Sheet Information \\ June 30,2020 \\ \hline Long-term debt \end{tabular} Notes payable, 10% 8x convertible bonds payable 10xibonds payable. Total longterm debt Shareholders' equity Preferred stock, 7% cumulative, $50 par value. 101,000 shares authorized, 25,250 shares issued and outstanding Common stock, 51 par, 10,100,000 shares authorized. 1,010,000 shares issued and outstanding Additional paid in capital Retained earnings Total thareholders' equity The following transactions have akso occurred at Marigold 1. Options were granted on luty 1.2019, to purehase 180,000 shares at $16 per share. Although no options were exercised during fical year 2020 , the average price per comman share during fiseal year 2020 was $20 per share. 2. Each bond was issued at tace value the 8 convertible bonds will convert into common stock at 50 shares per 51.000 bond. The bonds are exerckable atter 5 years and were issued in niseal year 2019 3. The preferredstock was iswed in 2019 4. There are no preferred dividends in arreare; however, preferred dividends were not deciared in fical year 2020. 5. The 1.010.000 rraces of common stock were outt anding for the entire 2020 fiscal year. 6. Net income for tiscal year 2020 was 51,480.000, and the arerage income tax rate is 2008 . For the fical year ended june 30,2020 , cakculate the following for Marizold Pharmiceutical industries. (Round answers to 2 decimal places, e.s. 32,45 .) (a) Basic eamines per thare For the fiscal year ended June 30,2020 , calculate the following for Marigold Pharmaceutical Industries. (Round answers to 2 decimal places, e.8. $2.45.) (a) Basic earnings per share. Basic earnings per share (b) Diluted earnings per share. Diluted earnings per share
